Laminin Product List
You Have Viewed 0 Of 0 Results
Clinical Drug Information
| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| Octahydroaminoacridine succinate | 华洋-001 | Phase 3 Clinical | Changchun Huayang High-Tech Co Ltd, Jiangsu Sheneryang High-Tech Co Ltd | Alzheimer Disease | Details |
| Bisnorcymserine | ANVS-301 | Phase 1 Clinical | Horizon Therapeutics PLC | Alzheimer Disease | Details |
Marketed Drug Information
| English Name | Research Code | Highest Development Stage | Company | Earliest Brand Name | Earliest Approval Country | Earliest Indication | Earliest Approval Company | Earliest Approval Date | Indication | Clinical Trial |
|---|---|---|---|---|---|---|---|---|---|---|
| Rivastigmine Tartrate | SDZ-212-713; SDZ 212713; SDZ-ENA-713; ONO-2540; ENA-713; ENA-713D | Approved | Novartis Pharma Ag | Exelon TDS, Rivastach, Exelon MR, Prometax, Exelon, 艾斯能 | EU | Parkinson Disease; Dementia; Alzheimer Disease | Novartis Europharm Ltd | 1998-05-11 | Substance-Related Disorders; Brain Injuries, Traumatic; Down Syndrome; Delirium; Neurobehavioral Manifestations; Alzheimer Disease; Dementia; Parkinson Disease; Cocaine-Related Disorders; Dementia, Vascular; Cognition Disorders; Anticholinergic Syndrome | Details |